|
|
|
Volumn 56, Issue 1433, 2014, Pages 1-2
|
|
Simeprevir (Olysio) for chronic hepatitis C
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATORVASTATIN;
BILIRUBIN;
BOCEPREVIR;
CYTOCHROME P450 3A;
MULTIDRUG RESISTANCE PROTEIN;
OLYSIO;
PEGINTERFERON;
RIBAVIRIN;
ROSUVASTATIN;
SIMEPREVIR;
SOFOSBUVIR;
SOVALDI;
TELAPREVIR;
UNCLASSIFIED DRUG;
DRUG EFFICACY;
HEPATITIS C;
HUMAN;
NOTE;
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
RANDOMIZED CONTROLLED TRIAL (TOPIC);
STEVENS JOHNSON SYNDROME;
|
|
EID: 84891658426
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (7)
|
|
References (4)
|
